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Priming the Search for HOX Mutations
The article by Kosaki et al. (p. 50) illustrates the
power of the ever-expanding DNA sequence databases
in greatly accelerating the development of tools for
genomic mutation discovery. In this case the authors
have developed coding sequence PCR primer sets for a
large, highly conserved group of transcription factors,
the HOX genes, whose full mutation spectrum in hu-
mans has not been elucidated. Due to their broad and
important biological roles, it is anticipated that the
availability of these sets will facilitate the identifica-
tion of mutations or polymorphisms in HOX genes in a
wide variety of phenotypes.
HOX gene mutations in humans associated with spe-
cific defects have been described for only three of the 39
known genes, HOXD13, HOXA13, and HOXA11. Ex-
cept for the newly described mutation in human
HOXA11, this subject has been reviewed (Innis, ‘97;
Veraksa et al., ‘00; Goodman and Scambler, ‘01). All of
these human syndromes are associated with heterozy-
gous HOX mutations that are inherited in an autoso-
mal dominant pattern with almost complete pen-
etrance. Two spontaneous coding sequence Hox mouse
mutants have been identified (Mortlock et al., ‘96;
Johnson et al., ‘98), and many of the Hox genes have
been “knocked out” in mice via homologous recombina-
tion in embryonic stem cells. Mice carrying heterozy-
gous, engineered null mutations for these genes often
exhibit incomplete penetrance, which has been attrib-
uted in large part to functional overlap of HOX proteins
to the growth and allocation of mesenchyme (Davis and
Capecchi, ‘96; Fromental-Ramain et al., ‘96; Zakany et
al., ‘97; Greer et al., ‘00). Stochastic variables and back-
ground genetic effects may also play a role and pheno-
typic differences with humans may reflect the nature of
the mutations or variation between species. A brief
glance at the human conditions caused by these muta-
tions, as well as the available mouse models illustrates
the future of HOX mutation searches.
HOXD13 mutations in synpolydactyly involve an ex-
pansion of an endogenous homopolymeric alanine re-
peat with increasing severity related to increased ex-
pansion length, and mice heterozygous for Hoxd13
alanine expansions are very similar (Muragaki et al.,
‘96; Akarsu et al., ‘96; Goodman et al., ‘97; Johnson et
al., ‘98). A different, and distinct, limb malformation
occurs with human intragenic HOXD13 deletions, sug-
gesting that HOXD13 alanine expansions act through
a gain-of-function (Goodman et al., ‘98). Hoxd13 engi-
neered null mice exhibit malformations distinct from
human intragenic HOXD13 deletion, suggesting that
the roles of the genes in mice may differ in comparison
to humans (Dolle et al., ‘93; Davis and Capecchi, ‘96). It
is also possible that differences in this comparison re-
sult from some remaining function of mutant human
HOXD13 proteins or unforeseen experimental conse-
quences of engineered null alleles in mice.
Sporadic or familial point mutations and alanine
tract expansion of HOXA13 have been reported in
hand-foot-genital syndrome (Mortlock and Innis, ‘97;
Goodman et al., ‘00). A constitutional deletion of 7p14-
p15 causing a loss of the entire HOXA cluster including
HOXA13 results in a phenotype similar to hand-foot-
genital syndrome in addition to other anomalies
(Devriendt et al., ‘99). Therefore, except for a patient
with a missense mutation in the homeodomain, which
may lead to a gain-of-function (Goodman et al., 2000),
haploinsufficiency of HOXA13 function is sufficient to
observe hand-foot-genital syndrome. Similar defects to
human HOXA13 haploinsufficiency were observed in
the mouse mutant Hypodactyly, however, this muta-
tion is a simultaneous loss and gain of function and is
more severe than the engineered Hoxa13 knockout
(Mortlock et al., ‘96; Fromental-Ramain et al., ‘96; Post
and Innis, ‘99; Post et al., ‘00).
A unique combination of radio-ulnar synostosis and
amegakaryocytic thrombocytopenia has been reported
for heterozygous HOXA11 homeodomain mutations in
humans (Thompson and Nguyen, ‘00). Whether or not
there are other skeletal manifestations in these pa-
tients remains to be determined, however, mice with
engineered null alleles of Hoxa11 have a dissimilar
skeletal phenotype and have not been reported to have
thrombocytopenia (Small and Potter, ‘93). These data
suggest that the human mutation may not be simply a
null allele or that the function of HOXA11 in humans
may be different compared to mice.
How does this information impact human HOX mu-
tation search strategies and interpretation? First,
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model system phenotypes are extremely valuable in
predicting domains of effect, if not identical human
malformations, associated with HOX gene mutations
and in guiding gene searches. Those searches may also
be guided by model system Hox expression data, e.g.,
available at the Mouse Genome Informatics database
at The Jackson Laboratory, and allow investigators to
actively consider alternative sites of malformation or
alteration in physiological function. On the other hand,
the phenotypic differences suggest caution in drawing
conclusions about the genetic basis of a phenotype or in
the prediction of a phenotype from a specific mutation.
Humans appear to exhibit greater phenotypic effects
and penetrance for presumed null mutations than do
mice, however, we cannot exclude a bias of ascertain-
ment in the cases that have so far been reported. If a
substantial fraction of mice show no evident abnormal-
ities when carrying heterozygous null mutations, then
it seems quite possible that a fraction of the human
population may also. In this case, some HOX loss of
function mutations could be overlooked potentially
leading to over-representation by gain-of-function sin-
gle gene HOX mutation discoveries in the future. Given
the degree of functional redundancy among HOX pro-
teins in endogenous, overlapping domains as demon-
strated in mouse models (Greer et al., ‘01), it will now
be easier to screen multiple genes within paralogous
groups in cases of malformations suggestive of HOX
mutations. Although all human HOX gene mutations
described so far affect the coding sequence, failure to
identify a coding sequence alteration in suspect cases
should prompt investigators to examine for larger re-
arrangements, as well as to sequence promoters, in-
trons, and untranslated regions.
The HOX PCR primer sets will also be useful for
identifying the full population spectra of HOX protein
polymorphisms. Efforts to determine the relationship
of any polymorphism to malformation parallel interna-
tional efforts to associate SNP combinations with com-
mon disease risk. The contribution of environment to
risk of individuals with certain Hox polymorphisms, or
even clearly deleterious mutations, must also be exam-
ined, especially in light of recent findings relative to
valproic acid, hyperthermia and diabetes in animal
models (Jacobs et al., ‘98; Li and Shiota, ‘99; Faiella et
al., ‘00). In addition, the utility of this comprehensive
primer set extends beyond causes of malformations.
Many Hox genes are expressed in adult organ systems
including blood, genitourinary tract, gut, kidney and
skin and their roles in these organ systems are not yet
known. A broader role in leukemia and solid tumors in
being investigated (Cillo et al., ‘99), and a disruption of
hindbrain patterning via HOX mutation is an attrac-
tive hypothesis, although unproved, for autism spec-
trum disorders (Ingram et al., ‘00).
The absence of detectable HOX coding mutations in
patients with highly suggestive patterns of defects
could result from chromosomal (visible cytogenetically
or submicroscopic) deletion. This was evident in the
findings by Devriendt et al. (‘99) who reported the
occurrence of hand-foot-genital syndrome, velopharyn-
geal insufficiency and persistent patent ductus Botalli
in a patient with a chromosomal deletion involving the
entire HOXA cluster, and in the patient reported by
Del Campo et al. (‘99) with a HOXD cluster deletion,
monodactylous limbs and abnormal genitalia. All pa-
tients should have high-quality karyotypes supple-
mented if possible with FISH or genomic marker data
to define deletion endpoints. Such deletions or translo-
cations, though rare, may offer valuable insight into
the regulation of the HOX genes in various organ sys-
tems.
Other than coding mutations and large chromosomal
rearrangements, mutations within promoters, enhanc-
ers or insulators could exert major phenotypic effects
by changing the level, domain or timing of HOX expres-
sion in the embryo. HOX proteins ectopically expressed
in regions more anterior or proximal than usual gen-
erally exert functional dominance over other HOX gene
products, giving rise to malformations or “posterior”
transformations of axial or limb structures (Duboule
and Morata, ‘94). This interesting aspect of Hox func-
tion noted initially in Drosophila (termed phenotypic
suppression), and subsequently in mice (posterior prev-
alence), is poorly understood at the molecular level.
The mouse Ulnaless mutant is a well-known example
of a vertebrate Hox regulatory mutation that alters the
expression level in the autopod, as well as the domain
for Hoxd13 and Hoxd12 to more anterior regions of the
developing limb resulting in reduction deficiency
(Peichel et al., ‘97; Herault et al., ‘97). Its molecular
identity remains elusive even though it is tightly
linked to the Hoxd cluster. Most likely conserved in
humans, the site of disruption in Ulnaless would be a
logical place to explore for mutations in humans with
various segmental deficiencies, or perhaps polydactyly.
Identification and characterization of enhancer and in-
sulator elements in model systems would facilitate
identification of such regulatory mutations in humans
(Kmita et al., ‘00; Spitz et al., ‘01). In the context of
HOX gene regulation, the influence of the Polycomb
and Trithorax genes, as well as HOX cofactors, should
also be considered in the evaluation of phenotype (see
reviews Schumacher and Magnuson, ‘97; Mann and
Affolter, ‘98; Veraksa et al., ‘00).
In summary, teratologists, physicians and molecular
geneticists have long been cognizant of the likely exis-
tence of HOX mutations in the pathology of malforma-
tions. Given that mutations have been identified in
three HOX genes, we look with anticipation to the
others. The tools provided by Kosaki et al. bring us
much closer to finding and learning more about the
roles of HOX proteins in humans.
JEFFREY W. INNIS*
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